echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Associate Professor Xiao Yuling and Professor Cai Lin of Zhongnan Hospital have made new progress in osteosarcoma imaging and synergistic treatment

    Associate Professor Xiao Yuling and Professor Cai Lin of Zhongnan Hospital have made new progress in osteosarcoma imaging and synergistic treatment

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     

    Recently, Chemical Engineering Journal (Impact Factor IF=1273 ), an internationally renowned journal under Elsevier , published online the application of near-infrared second-region small molecules for osteosarcoma targeted imaging and synergistic therapy by the Institute of Pharmacy, Zhongnan Hospital, Wuhan Universi.


    Osteosarcoma is a malignant tumor originating from mesenchymal tissue, which is prone to occur in adolescents and has a high morbidity and mortality ra.


    Paper link: https://d.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.